BioSpace News Archive

The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, will feature new products and technology solutions shaping new standards of care for modern day orthopaedics during the American Academy of Orthopaedic Surgeons (AAOS) annual meeting

VESTECK, Inc., an early-stage medical device company, is pleased to announce its initial close on $4.3M of Series A financing, which includes conversion of all existing convertible notes.

According to the report, the global veterinary teleradiology market was valued over US$ 200 Mn in 2020.

According to the report, the global Lyme disease diagnostics market was valued at ~US$ 2 Bn in 2020 and is projected to expand at a CAGR of 4% from 2021 to 2031.

The growing demand for quality and technologically advanced large molecule bioanalytical testing services will serve as a profitable growth-generating factor.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global poultry diagnostics market is anticipated to grow at 9% CAGR between 2021 and 2031 to reach valuation of nearly US$ 660 Mn by 2031.

According to the report, the global centrifugation-free sperm separation systems market was valued at US$ 100 Mn in 2019 and is projected to expand at a CAGR of ~4% from 2021 to 2031.

Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced that it has signed a letter of intent (“the LOI”) to acquire a biopharmaceutical company, the “Target Company”, commercializing COVID-19 antiviral oral therapy.

Provectus Algae, an Australian biotechnology platform company specialising in the biomanufacturing of high-value compounds for a wide array of industries using microalgae, announced they will be expanding into an additional large-scale manufacturing facility.

Moderna, Inc. today announced it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the full licensure of the Moderna COVID-19 Vaccine for active immunization to prevent COVID-19 in individuals 18 years of age and older.